Fischer V, Kretschmer M, Germain P, Kaur J, Mompart-Barrenechea S, Pelczar P
Transl Psychiatry. 2023; 13(1):378.
PMID: 38065942
PMC: 10709351.
DOI: 10.1038/s41398-023-02684-z.
Jaholkowski P, Hindley G, Shadrin A, Tesfaye M, Bahrami S, Nerhus M
Schizophr Bull. 2023; 49(6):1654-1664.
PMID: 37163672
PMC: 10686370.
DOI: 10.1093/schbul/sbad063.
Pinho-Gomes A, Gong J, Harris K, Woodward M, Carcel C
BMJ Neurol Open. 2022; 4(2):e000261.
PMID: 36110923
PMC: 9445798.
DOI: 10.1136/bmjno-2021-000261.
Baltanas F, Garcia-Navas R, Santos E
Int J Mol Sci. 2021; 22(12).
PMID: 34205562
PMC: 8234257.
DOI: 10.3390/ijms22126613.
Fernandez-Medarde A, Santos E
Methods Mol Biol. 2021; 2262:361-395.
PMID: 33977490
DOI: 10.1007/978-1-0716-1190-6_23.
Insulin Peptides as Mediators of the Impact of Life Style in Alzheimer's disease.
Fernandez A, Santi A, Torres Aleman I
Brain Plast. 2018; 4(1):3-15.
PMID: 30564544
PMC: 6297900.
DOI: 10.3233/BPL-180071.
Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review.
Lemche E
Curr Genomics. 2018; 19(7):522-602.
PMID: 30386171
PMC: 6194433.
DOI: 10.2174/1389202919666171229145156.
The PPARG Pro12Ala Polymorphism and 20-year Cognitive Decline: Race and Sex Heterogeneity.
West N, Tingle J, Simino J, Selvin E, Bressler J, Mosley Jr T
Alzheimer Dis Assoc Disord. 2017; 32(2):131-136.
PMID: 29116943
PMC: 5938164.
DOI: 10.1097/WAD.0000000000000217.
Interaction between PPAR γ and SORL1 gene with Late-Onset Alzheimer's disease in Chinese Han Population.
Zhang H, Zheng W, Hua L, Wang Y, Li J, Bai H
Oncotarget. 2017; 8(29):48313-48320.
PMID: 28427149
PMC: 5564649.
DOI: 10.18632/oncotarget.15691.
Gene- Gene Interaction between PPARG and APOE Gene on Late-Onset Alzheimer's Disease: A Case- Control Study in Chinese Han Population.
Wang S, Guan L, Luo D, Liu J, Lin H, Li X
J Nutr Health Aging. 2017; 21(4):397-403.
PMID: 28346566
DOI: 10.1007/s12603-016-0794-y.
Cognitive decline and the PPAR-γ Pro12Ala genotype: variation by sex and ethnicity.
West N, Baxter J, Bryant L, Nelson T
Age Ageing. 2017; 46(1):96-100.
PMID: 28181642
PMC: 6396745.
DOI: 10.1093/ageing/afw177.
Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.
Daniels M, Kan C, Willmes D, Ismail K, Pistrosch F, Hopkins D
Pharmacogenomics J. 2016; 16(5):399-410.
PMID: 27432533
DOI: 10.1038/tpj.2016.54.
Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences.
Mielke M, Vemuri P, Rocca W
Clin Epidemiol. 2014; 6:37-48.
PMID: 24470773
PMC: 3891487.
DOI: 10.2147/CLEP.S37929.
Lack of Genetic Associations of PPAR-γ and PGC-1α with Alzheimer's Disease and Parkinson's Disease with Dementia.
Shibata N, Motoi Y, Tomiyama H, Ohnuma T, Kuerban B, Tomson K
Dement Geriatr Cogn Dis Extra. 2013; 3(1):161-7.
PMID: 23741228
PMC: 3670632.
DOI: 10.1159/000351419.
Concerted perturbation observed in a hub network in Alzheimer's disease.
Liang D, Han G, Feng X, Sun J, Duan Y, Lei H
PLoS One. 2012; 7(7):e40498.
PMID: 22815752
PMC: 3398025.
DOI: 10.1371/journal.pone.0040498.
Impact and Therapeutic Potential of PPARs in Alzheimer's Disease.
Heneka M, Reyes-Irisarri E, Hull M, Kummer M
Curr Neuropharmacol. 2012; 9(4):643-50.
PMID: 22654722
PMC: 3263458.
DOI: 10.2174/157015911798376325.
Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease.
Sodhi R, Singh N, Jaggi A
Naunyn Schmiedebergs Arch Pharmacol. 2011; 384(2):115-24.
PMID: 21607645
DOI: 10.1007/s00210-011-0654-6.
The relationship of diet and acne: A review.
Pappas A
Dermatoendocrinol. 2010; 1(5):262-7.
PMID: 20808513
PMC: 2836431.
DOI: 10.4161/derm.1.5.10192.
Intermediate phenotypes identify divergent pathways to Alzheimer's disease.
Shulman J, Chibnik L, Aubin C, Schneider J, Bennett D, De Jager P
PLoS One. 2010; 5(6):e11244.
PMID: 20574532
PMC: 2888589.
DOI: 10.1371/journal.pone.0011244.
Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice.
Killick R, Scales G, Leroy K, Causevic M, Hooper C, Irvine E
Biochem Biophys Res Commun. 2009; 386(1):257-62.
PMID: 19523444
PMC: 2726921.
DOI: 10.1016/j.bbrc.2009.06.032.